Corcept Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. 

CEO
Joseph K. Belanoff
CEOJoseph K. Belanoff
Employees
730
Employees730
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1998
Founded1998
Employees
730
Employees730

CORT Key Statistics

Market cap
4.66B
Market cap4.66B
Price-Earnings ratio
53.39
Price-Earnings ratio53.39
Dividend yield
Dividend yield
Average volume
1.25M
Average volume1.25M
High today
$44.42
High today$44.42
Low today
$43.27
Low today$43.27
Open price
$43.76
Open price$43.76
Volume
337.03K
Volume337.03K
52 Week high
$91.00
52 Week high$91.00
52 Week low
$28.66
52 Week low$28.66

Stock Snapshot

Corcept Therapeutics(CORT) stock is priced at $43.81, giving the company a market capitalization of 4.66B. It carries a P/E multiple of 53.39.

During the trading session on 2026-04-15, Corcept Therapeutics(CORT) shares reached a daily high of $44.42 and a low of $43.27. At a current price of $43.81, the stock is +1.2% higher than the low and still -1.4% under the high.

Trading volume for Corcept Therapeutics(CORT) stock has reached 337.03K, versus its average volume of 1.25M.

The stock's 52-week range extends from a low of $28.66 to a high of $91.00.

The stock's 52-week range extends from a low of $28.66 to a high of $91.00.

CORT News

Simply Wall St 3d
Is Corcept Therapeutics Pricing Look Out Of Sync After Recent 30% Surge

Wondering if Corcept Therapeutics at around US$41.91 is a bargain or fully priced? This article breaks down what the current share price might be implying about...

Is Corcept Therapeutics Pricing Look Out Of Sync After Recent 30% Surge
TipRanks 5d
Corcept Therapeutics presents final overall survival data from ROSELLA trial

Corcept Therapeutics (CORT) presented final overall survival data from its pivotal Phase 3 ROSELLA trial of Lifyorli combined with the chemotherapeutic agent na...

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.